{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T23:55:23Z","timestamp":1672962923135},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2013,4,2]],"date-time":"2013-04-02T00:00:00Z","timestamp":1364860800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0060825","type":"journal-article","created":{"date-parts":[[2013,4,2]],"date-time":"2013-04-02T21:56:17Z","timestamp":1364939777000},"page":"e60825","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Characterization of Tat Antibody Responses in Chinese Individuals Infected with HIV-1"],"prefix":"10.1371","volume":"8","author":[{"given":"Qiuli","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenting","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huaqun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojie","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingying","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,4,2]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1742-4690-6-50","article-title":"What does the structure-function relationship of the HIV-1 Tat protein teach us about developing an AIDS vaccine?","volume":"6","author":"GR Campbell","year":"2009","journal-title":"Retrovirology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jmb.2010.10.033","article-title":"Fab'-induced folding of antigenic N-terminal peptides from intrinsically disordered HIV-1 Tat revealed by X-ray crystallography","volume":"405","author":"J Serriere","year":"2011","journal-title":"J Mol Biol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1046\/j.1432-1033.2003.03568.x","article-title":"Different modes of dipeptidyl peptidase IV (CD26) inhibition by oligopeptides derived from the N-terminus of HIV-1 Tat indicate at least two inhibitor binding sites","volume":"270","author":"S Lorey","year":"2003","journal-title":"Eur J Biochem"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"6594","DOI":"10.1073\/pnas.91.14.6594","article-title":"Human immunodeficiency virus 1 Tat binds to dipeptidyl aminopeptidase IV (CD26): a possible mechanism for Tat's immunosuppressive activity","volume":"91","author":"WG Gutheil","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"22180","DOI":"10.1074\/jbc.M002338200","article-title":"Down-regulation of T cell activation following inhibition of dipeptidyl peptidase IV\/CD26 by the N-terminal part of the thromboxane A2 receptor","volume":"275","author":"S Wrenger","year":"2000","journal-title":"J Biol Chem"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/nature09131","article-title":"Crystal structure of HIV-1 Tat complexed with human P-TEFb","volume":"465","author":"TH Tahirov","year":"2010","journal-title":"Nature"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/nsmb.1513","article-title":"Structural insights into the cyclin T1-Tat-TAR RNA transcription activation complex from EIAV","volume":"15","author":"K Anand","year":"2008","journal-title":"Nat Struct Mol Biol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JVI.63.1.1-8.1989","article-title":"Structural and functional characterization of human immunodeficiency virus tat protein","volume":"63","author":"S Ruben","year":"1989","journal-title":"J Virol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"16010","DOI":"10.1074\/jbc.272.25.16010","article-title":"A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus","volume":"272","author":"E Vives","year":"1997","journal-title":"J Biol Chem"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1097\/00002030-199712000-00006","article-title":"HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region","volume":"11","author":"HC Chang","year":"1997","journal-title":"Aids"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1128\/JVI.67.1.277-287.1993","article-title":"Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation","volume":"67","author":"B Ensoli","year":"1993","journal-title":"J Virol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"8324","DOI":"10.1073\/pnas.96.15.8324","article-title":"Tat as one key to HIV-induced immune pathogenesis and Pat toroid as an important component of a vaccine","volume":"96","author":"RC Gallo","year":"1999","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref13","first-page":"137","article-title":"Antibody spectrum against the viral transactivator protein in patients with human immunodeficiency virus type 1 infection and Kaposi's sarcoma","volume":"3","author":"I Demirhan","year":"2000","journal-title":"J Hum Virol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/jmv.1890260306","article-title":"Natural antibodies to HIV-tat epitopes and expression of HIV-1 genes in vivo","volume":"26","author":"WJ Krone","year":"1988","journal-title":"J Med Virol"},{"key":"ref15","first-page":"282","article-title":"Antibodies to the HIV-1 Tat protein correlated with nonprogression to AIDS: a rationale for the use of Tat toxoid as an HIV-1 vaccine","volume":"1","author":"JF Zagury","year":"1998","journal-title":"J Hum Virol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1086\/378412","article-title":"Sequence conservation and antibody cross-recognition of clade B human immunodeficiency virus (HIV) type 1 Tat protein in HIV-1-infected Italians, Ugandans, and South Africans","volume":"188","author":"S Butto","year":"2003","journal-title":"J Infect Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1086\/428909","article-title":"The presence of anti-Tat antibodies is predictive of long-term nonprogression to AIDS or severe immunodeficiency: findings in a cohort of HIV-1 seroconverters","volume":"191","author":"G Rezza","year":"2005","journal-title":"J Infect Dis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.vaccine.2009.10.038","article-title":"The preventive phase I trial with the HIV-1 Tat-based vaccine","volume":"28","author":"B Ensoli","year":"2009","journal-title":"Vaccine"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/978-1-4419-1132-2_14","article-title":"Innovative approaches to develop prophylactic and therapeutic vaccines against HIV\/AIDS","volume":"655","author":"A Cafaro","year":"2009","journal-title":"Adv Exp Med Biol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1089\/aid.2007.0171","article-title":"Tat-specific binding IgG and disease progression in HIV type 1-infected Ugandans","volume":"24","author":"D Senkaali","year":"2008","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref21","first-page":"207","article-title":"Relationships between the presence of anti-Tat antibody, DNA and RNA viral load","volume":"24","author":"MC Re","year":"2001","journal-title":"New Microbiol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00190145","article-title":"Antibodies to recombinant HIV-1 vif, tat, and nef proteins in human sera","volume":"179","author":"U Wieland","year":"1990","journal-title":"Med Microbiol Immunol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1089\/dna.2007.0708","article-title":"Alternate arrangement of PpL B3 domain and SpA D domain creates synergistic double-site binding to VH3 and Vkappa regions of fab","volume":"27","author":"SH Jiang","year":"2008","journal-title":"DNA Cell Biol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"e18477","DOI":"10.1371\/journal.pone.0018477","article-title":"Novel evolved immunoglobulin (Ig)-binding molecules enhance the detection of IgM against hepatitis C virus","volume":"6","author":"J Cao","year":"2011","journal-title":"PLoS One"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1016\/j.vaccine.2012.01.055","article-title":"A designed Tat immunogen generates enhanced anti-Tat C-terminal antibodies","volume":"30","author":"W Liao","year":"2012","journal-title":"Vaccine"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1742-4690-3-53","article-title":"Transactivation and signaling functions of Tat are not correlated: biological and immunological characterization of HIV-1 subtype-C Tat protein","volume":"3","author":"NB Siddappa","year":"2006","journal-title":"Retrovirology"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"6739","DOI":"10.1016\/j.vaccine.2009.08.078","article-title":"HIV-1 Tat-specific IgG antibodies in high-responders target a B-cell epitope in the cysteine-rich domain and block extracellular Tat efficiently","volume":"27","author":"VP Kashi","year":"2009","journal-title":"Vaccine"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0764-4469(00)01228-2","article-title":"1H-13C nuclear magnetic resonance assignment and structural characterization of HIV-1 Tat protein","volume":"323","author":"JM Peloponese Jr","year":"2000","journal-title":"C R Acad Sci III"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0022-2836(05)80133-0","article-title":"Structural studies of HIV-1 Tat protein","volume":"247","author":"P Bayer","year":"1995","journal-title":"J Mol Biol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1742-4690-5-83","article-title":"Homonuclear 1H NMR and circular dichroism study of the HIV-1 Tat Eli variant","volume":"5","author":"JD Watkins","year":"2008","journal-title":"Retrovirology"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"8347","DOI":"10.1074\/jbc.M510748200","article-title":"HIV-1 Tat is a natively unfolded protein: the solution conformation and dynamics of reduced HIV-1 Tat-(1\u201372) by NMR spectroscopy","volume":"281","author":"S Shojania","year":"2006","journal-title":"J Biol Chem"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"11942","DOI":"10.1074\/jbc.M111.319863","article-title":"A monoclonal antibody directed against a conformational epitope of the HIV-1 trans-activator (Tat) protein neutralizes cross-clade","volume":"287","author":"S Mediouni","year":"2012","journal-title":"J Biol Chem"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0060825","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T18:47:36Z","timestamp":1595616456000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0060825"}},"subtitle":[],"editor":[{"given":"Ashok","family":"Chauhan","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,4,2]]},"references-count":32,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,4,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0060825","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,2]]}}}